Cancer management in which of the following malignancies has dramatically increase the survival:
**Core Concept**
The management of various cancers has evolved significantly over the years, with advancements in treatment modalities leading to improved survival rates. The question focuses on identifying a specific malignancy where cancer management has resulted in a dramatic increase in survival.
**Why the Correct Answer is Right**
The correct answer is associated with Hodgkin lymphoma, a type of cancer that affects the immune system. The introduction of combination chemotherapy, particularly ABVD (adriamycin, bleomycin, vinblastine, and dacarbazine), has revolutionized the treatment of Hodgkin lymphoma. This regimen has significantly improved the survival rates of patients with Hodgkin lymphoma, with some studies reporting 5-year survival rates exceeding 80%. The effectiveness of ABVD can be attributed to its ability to target rapidly dividing cancer cells, while minimizing damage to normal tissues.
**Why Each Wrong Option is Incorrect**
**Option A:** Leukemia management has seen improvements, but the dramatic increase in survival is more pronounced in other malignancies.
**Option B:** Breast cancer management has improved, but the introduction of targeted therapies and hormonal therapies has contributed more to the increase in survival rates.
**Option C:** Lung cancer management has seen some advancements, but the overall 5-year survival rate remains relatively low compared to other cancers.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that the ABVD regimen has become the standard of care for Hodgkin lymphoma due to its efficacy and relatively favorable side effect profile. This knowledge is crucial for medical professionals to provide optimal care for patients with this type of cancer.
**Correct Answer:** C.